Use of 2,3-diaryl-1-benzopyran derivatives for the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01) A61K 31/35 (2006.01) A61K 31/40 (2006.01)

Patent

CA 2180178

Methods and pharmaceutical compositions for reducing bone loss are disclosed. 2,3-Diaryl-1- benzopyrans and their pharmaceutically acceptable salts are formulated into medicaments for the treat- ment of bone loss due to osteoperosis or other con- ditions. Formulations include tablets and other forms suitable for oral administration and controlled-release subdermal implants.

L'invention se rapporte à des procédés et à des compositions pharmaceutiques utilisés pour réduire la diminution du volume du tissu osseux. Les formulations des 2,3-diaryl-1-benzopyranes et leurs sels pharmaceutiquement acceptables permettent d'obtenir des médicaments utilisés dans le traitement de la diminution du volume du tissu osseux due à l'ostéoporose ou à d'autres états. Ces formulations sont des comprimés et autres formes galéniques appropriées à l'administration orale et aux implants sous-dermiques à libération contrôlée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of 2,3-diaryl-1-benzopyran derivatives for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 2,3-diaryl-1-benzopyran derivatives for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2,3-diaryl-1-benzopyran derivatives for the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2002334

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.